- Who should be offered non-radical surgery for early-stage cervical cancer?
-
Bouchard-Fortier G, Covens A
- KMID: 2345911
- J Gynecol Oncol.
- 2015 Oct;26(4):243-245.
- doi: 10.3802/jgo.2015.26.4.243
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility-sparing surgery in high-risk ovarian cancer
-
Ditto A, Bogani G, Martinelli F, Raspagliesi F
- KMID: 2345927
- J Gynecol Oncol.
- 2015 Oct;26(4):350-351.
- doi: 10.3802/jgo.2015.26.4.350
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A critical assessment on the role of sentinel node mapping in endometrial cancer
-
Bogani G, Ditto A, Martinelli F, Signorelli M, Perotto S, Lorusso D, Raspagliesi F
- KMID: 2345914
- J Gynecol Oncol.
- 2015 Oct;26(4):252-254.
- doi: 10.3802/jgo.2015.26.4.252
Endometrial cancer is the most common gynecologic malignancy in the developed countries. Although the high incidence of this occurrence no consensus, about the role of retroperitoneal staging, still exists. Growing... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imaging
-
Lin MY, Jobling TW, Narayan K
- KMID: 2345928
- J Gynecol Oncol.
- 2015 Oct;26(4):352-354.
- doi: 10.3802/jgo.2015.26.4.352
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Wait times from diagnosis to treatment in cancer
-
Elit L
- KMID: 2345912
- J Gynecol Oncol.
- 2015 Oct;26(4):246-248.
- doi: 10.3802/jgo.2015.26.4.246
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma
-
Tjalma WA
- KMID: 2345929
- J Gynecol Oncol.
- 2015 Oct;26(4):355-356.
- doi: 10.3802/jgo.2015.26.4.355
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Role of aggressive surgical cytoreduction in advanced ovarian cancer
-
Chang SJ, Bristow RE, Chi DS, Cliby WA
- KMID: 2345925
- J Gynecol Oncol.
- 2015 Oct;26(4):336-342.
- doi: 10.3802/jgo.2015.26.4.336
Ovarian cancer is the eighth most frequent cancer in women and is the most lethal gynecologic malignancy worldwide. The majority of ovarian cancer patients are newly diagnosed presenting with advanced-stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Controversies in borderline ovarian tumors
-
Seong SJ, Kim DH, Kim MK, Song T
- KMID: 2345926
- J Gynecol Oncol.
- 2015 Oct;26(4):343-349.
- doi: 10.3802/jgo.2015.26.4.343
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal... -
- CITED
-
- Close
- SHARE
-
- Close
- Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
-
Lee JY, Kim K, Lee TS, Kang S, Seong SJ, Kim JW, Kim BG
- KMID: 2345918
- J Gynecol Oncol.
- 2015 Oct;26(4):277-283.
- doi: 10.3802/jgo.2015.26.4.277
OBJECTIVE: To identify current practice patterns for unresolved issues in the surgical and adjuvant management of endometrial cancer in Korea. METHODS: We designed and conducted a survey of all 218 active... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical application of sartorius tendon transposition during radical vulvectomy: a case control study of 58 cases at a single institution
-
Li L, Kou X, Feng X, Liu F, Chao H, Wang L
- KMID: 2345923
- J Gynecol Oncol.
- 2015 Oct;26(4):320-326.
- doi: 10.3802/jgo.2015.26.4.320
OBJECTIVE: The aim of this study was to investigate the clinical effects of sartorius tendon transposition versus sartorius transposition during bilateral inguinal lymphadenectomy of radical vulvectomy. METHODS: A total of 58... -
- CITED
-
- Close
- SHARE
-
- Close
- Uterine carcinosarcoma/malignant mixed Mullerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy
-
Wilson BT, Cordell HJ
- KMID: 2345913
- J Gynecol Oncol.
- 2015 Oct;26(4):249-251.
- doi: 10.3802/jgo.2015.26.4.249
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
-
Yamazaki H, Todo Y, Okamoto K, Yamashiro , Kato H
- KMID: 2345915
- J Gynecol Oncol.
- 2015 Oct;26(4):255-261.
- doi: 10.3802/jgo.2015.26.4.255
OBJECTIVE: All patients with stage IB1 cervical cancer do not need to undergo parametrectomy. Some low-risk criteria for parametrial involvement (PI) have been proposed based on pathological findings. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
-
Fujiwara S, Terai Y, Tsunetoh S, Sasaki H, Kanemura M, Ohmichi M
- KMID: 2345922
- J Gynecol Oncol.
- 2015 Oct;26(4):311-319.
- doi: 10.3802/jgo.2015.26.4.311
OBJECTIVE: There is no research regarding the appropriate antiemetic agents for female patients, especially those receiving moderately emetogenic chemotherapy (MEC). We evaluated the antiemetic efficacy of a combination of 5-HT3... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors
-
Paik ES, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG
- KMID: 2345917
- J Gynecol Oncol.
- 2015 Oct;26(4):270-276.
- doi: 10.3802/jgo.2015.26.4.270
OBJECTIVE: The aim of this study was to investigate outcomes in uterine cancer patients undergoing pulmonary metastasectomy and prognostic factors associated with survival after the procedure. METHODS: A retrospective study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival
-
Nanthamongkolkul K, Hanprasertpong J
- KMID: 2345916
- J Gynecol Oncol.
- 2015 Oct;26(4):262-269.
- doi: 10.3802/jgo.2015.26.4.262
OBJECTIVE: The aim of this study was to evaluate the impact of surgical waiting time on clinical outcome in early stage cervical cancer. METHODS: The cohort consisted of 441 patients diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
- Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand
-
Tangjitgamol S, Khunnarong J, Srijaipracharoen S
- KMID: 2345920
- J Gynecol Oncol.
- 2015 Oct;26(4):293-302.
- doi: 10.3802/jgo.2015.26.4.293
OBJECTIVE: To evaluate the prevalence and features of non-endometrial cancers in Thai endometrial cancer (EC) patients. METHODS: EC patients treated in our institution were identified and the following data were collected:... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library
-
Shi LF, Wu Y, Li CY
- KMID: 2345924
- J Gynecol Oncol.
- 2015 Oct;26(4):327-335.
- doi: 10.3802/jgo.2015.26.4.327
OBJECTIVE: Vascular endothelial growth factor (VEGF) interaction with its receptor, VEGFR-3/Flt-4, regulates lymphangiogenesis. VEGFR-3/Flt-4 expression in cancer cells has been correlated with clinical stage, lymph node metastasis, and lymphatic invasion.... -
- CITED
-
- Close
- SHARE
-
- Close
- Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer
-
Signorelli M, Lissoni AA, De Ponti E, Grassi T, Ponti S, Fruscio R
- KMID: 2345919
- J Gynecol Oncol.
- 2015 Oct;26(4):284-292.
- doi: 10.3802/jgo.2015.26.4.284
OBJECTIVE: Evaluation of the impact of sequential chemoradiotherapy in high risk endometrial cancer (EC). METHODS: Two hundred fifty-four women with stage IB grade 3, II and III EC (2009 FIGO staging),... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
-
Iwase H, Takada T, Iitsuka C, Nomura H, Abe A, Taniguchi , Takizawa K
- KMID: 2345921
- J Gynecol Oncol.
- 2015 Oct;26(4):303-310.
- doi: 10.3802/jgo.2015.26.4.303
OBJECTIVE: To investigate the clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery (IDS) in advanced epithelial ovarian cancer (EOC) patients. METHODS: We retrospectively reviewed the medical records of 124... -
- CITED
-
- Close
- SHARE
-
- Close
